Subcutaneous Amivantamab Allows for Potential Increases in Adherence, Treatment Options: Martin Dietrich, MD, PhDByJulia Bonavitacola,Martin Dietrich, MD, PhDDecember 28th 2025
Advancing Treatment Options for Pediatric Myasthenia Gravis: A Q&A With Jonathan Strober, MDByMaggie L. Shaw,Jonathan Strober, MDDecember 28th 2025